105 related articles for article (PubMed ID: 1530305)
1. [Experimental study on adequate 5-FU dose and flow volume for continuous arterial liver infusion].
Mori T; Iwasaki Y; Takahashi K; Takahashi T
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1547-9. PubMed ID: 1530305
[TBL] [Abstract][Full Text] [Related]
2. [Experimental study of 5-FU + leucovorin therapy by continuous arterial infusion].
Mori T
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2838-41. PubMed ID: 2789495
[TBL] [Abstract][Full Text] [Related]
3. [Distribution of 5-FU in rat plasma and liver tissue after local 5-FU infusion].
Zheng JL; Liang LJ; Hu WJ; Shen SL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):823-7. PubMed ID: 18504211
[TBL] [Abstract][Full Text] [Related]
4. [Validity of two-hour continuous hepatic arterial infusion chemotherapy with low-dose 5-FU for unresectable liver metastasis from colorectal cancer].
Kosaka K; Nishino H; Yamada N; Nishihara T; Ohira M; Hirakawa K
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1647-50. PubMed ID: 14619485
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of 5-fluorouracil concentration in peripheral blood and side effects in continuous hepatic arterial infusion chemotherapy for patients with unresectable liver cancer].
Fujii K; Nakashima K; Ohno T; Anai H
Gan To Kagaku Ryoho; 1997 Sep; 24(12):1835-7. PubMed ID: 9382545
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of continuous hepatic arterial infusion of high-dose 5-FU for liver metastases of gastric cancer].
Hasuike Y; Takeda Y; Hosoki T; Sai H; Tsujinaka T; Mitomo M
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1728-31. PubMed ID: 11708019
[TBL] [Abstract][Full Text] [Related]
7. [Experimental studies on the optimal therapeutic mode of intra-arterial infusion of 5-fluorouracil. (2) Concentrations within the tumors and normal tissues and therapeutic and adverse effects of 5-fluorouracil delivered by various routes].
Ota J
Gan To Kagaku Ryoho; 1983 Nov; 10(11):2362-9. PubMed ID: 6639098
[TBL] [Abstract][Full Text] [Related]
8. [An effective case of arterial infusion therapy of low-dose CDDP and continuous 5-FU for isolated hepatic recurrence of gastric carcinoma].
Akamo Y; Takeyama H; Mohri N; Teranishi F; Ohara E; Kawashima N; Hayakawa T; Fukui T; Tanaka M; Mizuno I; Manabe T
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1945-7. PubMed ID: 10560432
[TBL] [Abstract][Full Text] [Related]
9. [Continuous hepatic arterial infusion chemotherapy with low-dose CDDP plus 5-FU for liver metastases from colorectal carcinoma].
Kohnoe S; Taketomi A; Morita M; Baba H; Matsuoka H; Seo Y; Saito T; Tomoda H
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1429-32. PubMed ID: 8854771
[TBL] [Abstract][Full Text] [Related]
10. [In vivo comparative study of the pharmacokinetics of chemotherapeutic agents infused via hepatic artery or portal vein against hepatic metastases. DRC Group].
Naomoto Y; Gochi A; Hizuta A; Iwagaki H; Matsuno T; Hamazaki K; Tanaka N; Orita K
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1555-8. PubMed ID: 8373217
[TBL] [Abstract][Full Text] [Related]
11. Stealth liposomal 5-fluorouracil with or without degradable starch microspheres for hepatic arterial infusion in the treatment of liver metastases. An animal study in VX-2 liver tumor-bearing rabbits.
Pohlen U; Reszka R; Schneider P; Buhr HJ; Berger G
Anticancer Res; 2004; 24(3a):1699-704. PubMed ID: 15274343
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetic studies on continuous intraportal 5-fluorouracil infusion].
Matsuzaki H; Yamamura T; Hanai A; Oikawa H; Kikuchi K; Seo K; Ozasa T; Akaishi O; Tsukikawa S; Yamaguchi S
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2121-3. PubMed ID: 7944418
[TBL] [Abstract][Full Text] [Related]
13. [Experimental studies on the optimal therapeutic mode of intra-arterial infusion of 5-fluorouracil. (1) Preparation of an animal model for continuous intra-arterial infusion and comparison of the therapeutic and adverse effects of 5-fluorouracil delivered by various modes].
Ota J
Gan To Kagaku Ryoho; 1983 Nov; 10(11):2353-61. PubMed ID: 6639097
[TBL] [Abstract][Full Text] [Related]
14. [Two cases of gastric cancer with multiple liver metastases responding to TS-1 with hepatic arterial infusion of CDDP following low-dose 5-FU and CDDP chemotherapy].
Hirohashi Y; Sumi K; Matsuyama S
Gan To Kagaku Ryoho; 2005 Jan; 32(1):85-8. PubMed ID: 15675589
[TBL] [Abstract][Full Text] [Related]
15. Hepatic arterial infusion of 5-fluorouracil for liver metastases from pancreatic carcinoma: results from a pilot study.
Furuse J; Maru Y; Yoshino M; Mera K; Sumi H; Tajiri H; Satake M; Onaya H; Ishikura S; Ogino T; Kawashima M; Ikeda H
Hepatogastroenterology; 2001; 48(37):208-11. PubMed ID: 11268967
[TBL] [Abstract][Full Text] [Related]
16. [Concentration of 5-FU after hepatic artery infusion chemotherapy for liver metastases of colorectal cancer].
Maruyama S; Ando M; Watayo T
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1635-8. PubMed ID: 14619482
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological evaluation of experimental isolated liver perfusion and hepatic artery infusion with 5-fluorouracil.
de Brauw LM; Marinelli A; van de Velde CJ; Hermans J; Tjaden UR; Erkelens C; de Bruijn EA
Cancer Res; 1991 Mar; 51(6):1694-700. PubMed ID: 1998960
[TBL] [Abstract][Full Text] [Related]
18. Regional pharmacokinetics of 5-bromo-2'-deoxyuridine and 5-fluorouracil in dogs: hepatic arterial versus portal venous infusions.
Kuan HY; Smith DE; Ensmiger WD; Knol JA; DeRemer SJ; Yang Z; Stetson PL
Cancer Res; 1996 Oct; 56(20):4724-7. PubMed ID: 8840990
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetic studies of continuous and bolus intraportal 5-fluorouracil infusion].
Hanai A; Yamamura T; Matsuzaki H; Oikawa H; Kikuchi K; Ozasa T; Akaishi O; Senda T; Katayama K
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1536-9. PubMed ID: 1530302
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacokinetics of "subselective" arterial infusion chemotherapy].
Tokairin Y; Maruyama M; Baba H; Yoshida T; Kure N; Nagahama T; Ebuchi M
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1795-8. PubMed ID: 11708037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
